BTCC / BTCC Square / Global Cryptocurrency /
Bluejay Diagnostics Stock Surges 115% on Expanded Partnership with SanyoSeiko

Bluejay Diagnostics Stock Surges 115% on Expanded Partnership with SanyoSeiko

Published:
2025-10-09 15:34:02
7
3
BTCCSquare news:

Bluejay Diagnostics (BJDX) shares soared 115% Thursday after announcing an expanded collaboration with Japan's SanyoSeiko to accelerate commercialization of its Symphony diagnostic platform. The medical device manufacturer will now provide end-to-end support, including manufacturing redevelopment, supply chain management, and contract production for analyzers and cartridges.

CEO Neil Dey framed the partnership as a strategic milestone, emphasizing strengthened supply chain resilience and production capacity ahead of broader clinical trials. The Symphony system aims to deliver rapid biomarker test results, positioning Bluejay in the growing point-of-care diagnostics market.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users